Literature DB >> 2014231

Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers.

T A Pham1, J F Elliston, Z Nawaz, D P McDonnell, M J Tsai, B W O'Malley.   

Abstract

We describe in this report experiments in vivo that demonstrate that antiestrogens promote DNA binding of the estrogen receptor without efficiently inducing transcription. When the receptor is modified to carry a foreign unregulated transactivation domain, transcription can be induced efficiently by both estrogen and antiestrogens. Under apparent saturation conditions, antihormone-receptor complexes binding to responsive enhancer elements elicit only a low level of transcription. In addition, we show that both estrogen and an antiestrogen, nafoxidine, effect very similar alterations in chromatin structure at a responsive promoter. These results indicate that in vivo steroid receptor action can be regulated subsequent to the DNA binding step, by regulating interactions with the target transcriptional machinery. In this regard, antihormones can function by establishing receptor-DNA complexes that are transcriptionally nonproductive.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014231      PMCID: PMC51398          DOI: 10.1073/pnas.88.8.3125

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  The human oestrogen receptor functions in yeast.

Authors:  D Metzger; J H White; P Chambon
Journal:  Nature       Date:  1988-07-07       Impact factor: 49.962

2.  Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.

Authors:  V K Moudgil; C Hurd
Journal:  Biochemistry       Date:  1987-08-11       Impact factor: 3.162

3.  In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone.

Authors:  P B Becker; B Gloss; W Schmid; U Strähle; G Schütz
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

4.  Steroid-free glucocorticoid receptor binds specifically to mouse mammary tumour virus DNA.

Authors:  T Willmann; M Beato
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

5.  Differences between oestrogen receptor activation by oestrogen and antioestrogen.

Authors:  H Rochefort; J L Borgna
Journal:  Nature       Date:  1981-07-16       Impact factor: 49.962

6.  Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro.

Authors:  A Groyer; G Schweizer-Groyer; F Cadepond; M Mariller; E E Baulieu
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  Desmethylnafoxidine aziridine: an electrophilic affinity label for the estrogen receptor with high efficiency and selectivity.

Authors:  D M Simpson; J F Elliston; J A Katzenellenbogen
Journal:  J Steroid Biochem       Date:  1987-09       Impact factor: 4.292

8.  Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor.

Authors:  P J Weatherill; A P Wilson; R I Nicholson; P Davies; A E Wakeling
Journal:  J Steroid Biochem       Date:  1988       Impact factor: 4.292

9.  Nuclease hypersensitive regions with adjacent positioned nucleosomes mark the gene boundaries of the PHO5/PHO3 locus in yeast.

Authors:  A Almer; W Hörz
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  24 in total

1.  Ligand dependence of estrogen receptor induced changes in chromatin structure.

Authors:  D M Gilbert; R Losson; P Chambon
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  Differential modes of activation define orphan subclasses within the steroid/thyroid receptor superfamily.

Authors:  J P Lydon; R F Power; O M Conneely
Journal:  Gene Expr       Date:  1992

3.  Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro.

Authors:  N D Arbuckle; S Dauvois; M G Parker
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

Review 4.  The future of antihormone therapy: innovations based on an established principle.

Authors:  K Parczyk; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.

Authors:  S Dauvois; P S Danielian; R White; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Identification of novel steroid-response elements.

Authors:  Z Nawaz; M J Tsai; D P McDonnell; B W O'Malley
Journal:  Gene Expr       Date:  1992

7.  Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.

Authors:  D Chen; P E Pace; R C Coombes; S Ali
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

8.  Regulation of tyrosine aminotransferase gene expression by glucocorticoids in quiescent and regenerating liver.

Authors:  L Baki; M N Alexis
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

9.  Cell cycle and anti-estrogen effects synergize to regulate cell proliferation and ER target gene expression.

Authors:  Mathieu Dalvai; Kerstin Bystricky
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

10.  A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens.

Authors:  S Y Jiang; C J Parker; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.